Lymphatic filariasis

Syllabus subtopic: Issues relating to development and management of Social Sector/Services relating to Health, education, Human Resources

News: National Symposium on Lymphatic Filariasis was held in India on the theme ‘United to Eliminate Lymphatic Filariasis’.

Prelims and Mains focus: about lymphatic filarisis, symptoms and its effects, Triple drug therapy, global concern

About Lymphatic filariasis:

Also called as elephantiasis, it is caused by infection with parasitic worms living in the lymphatic system. The larval stages of the parasite (microfilaria) circulate in the blood and are transmitted from person to person by mosquitoes.

May Cause abnormal enlargement of body parts, and leading to severe disability and social stigmatization of those affected

The parasites are transmitted by four main types of mosquitoes: Culex, Mansonia, Anopheles and Aedes.

Triple drug therapy:

The World Health Organization (WHO) is recommending three drug treatment to accelerate the global elimination of lymphatic filariasis.

The treatment, known as IDA, involves a combination of ivermectin, diethylcarbamazine citrate and albendazole.
The plan is to administer these drugs for two consecutive years. The life of the adult worm is hardly four years, so it would die a natural death without causing any harm to the person.

Need for and significance of the therapy:

Lymphatic filariasis poses a grave threat to India.
Over 40% of worldwide cases are found in India.
Since 2004, two drug therapy for lymphatic filariasis has been in place but the addition of the third drug now will give a boost to the overall campaign.
India has missed earlier deadlines to eradicate the disease by 2015 and 2017.
The global deadline now is 2020 and the three drug approach may help the country get there.

Global Alliance to Eliminate Lymphatic Filariasis:

It is an alliance of partners from 72 LF endemic national country programmes, NGOs, private sectors, academic and research institutes and international development agencies that assists WHO’s Global Programme to Eliminate Lymphatic Filariasis.

Source: The Hindu

Join Our Telegram

Cyclone Maha

Jadhav case: Pak violates its obligations

Pradhan Mantri Suryodaya Yojana

06 Feb, 24
SHARE

Recently, Prime Minister announced Pradhan Mantri Suryodaya Yojana under which 1 crore households will get rooftop solar power systems. India’s Status of Current Solar Capacity India currently stands at 4th place globally in solar power capacity. As per Ministry of New an

Foreign Contribution Regulation Act (FCRA)- NGO

06 Feb, 24
SHARE

The Foreign Contribution Regulation Act, 2010 (FCRA) registration of two prominent non-governmental organisations (NGOs) — Centre for Policy Research (CPR) and World Vision India (WVI) have been cancelled this month. What is FCRA? Key provisions of FCRA, 2010 Key aspects Description

Voice clone-AI

06 Feb, 24
SHARE

Voice clone fraud has been on the rise in India. AI voice cloning – It is the process of creating a synthetic replica of a person’s voice through machine learning and speech synthesis technology.It is called as voice deepfakesor audio deepfakes. Objective – To achieve a high level of na

Science communication- how to promote

06 Feb, 24
SHARE

Steps taken by India to promote Science Communication Publications and Information Directorate (PID) - An organisation under Council of Science and Industrial Research (CSIR) established in 1951 for publishing and disseminating scientific information in India. National science magazines- The PI

Universal Basic Income (UBI)- Analysis

05 Feb, 24
SHARE

Universal Basic Income (UBI) can strengthen welfare architecture and unlock the nation’s latent demographic potential. UBI - It is an income support mechanism typically intended to reach all or a very large portion of the population regardless of their earnings or employment status. Objective- To provide enough to co